Total pendapatan perusahaan NovaBay Pharmaceuticals Inc. (NBY)

Lambang korporat lan logo NovaBay Pharmaceuticals, Inc. (NBY)

NovaBay Pharmaceuticals (NBY) management is focusing on promoting ophthalmological and dermatological product lines through online platforms and retail to achieve profitability. However, retail distribution expansion has slowed, and revenue growth is being constrained by significant advertising expenses. The company's sales history based on GURU.Markets data is illustrated on this chart, where 0.00 reflects the baseline metric level, supported by a resilient antiseptic supply system that eliminates product shortages.

NBY - Pendapatan lan volume dodolan NovaBay ing rentang 04.07.2022 - 18.04.2026

Rincian metrik komprehensif lan analitis NovaBay (NBY)

- rega saiki lan proyeksi nilai saham:
Analisis umum perusahaan:NBY (NovaBay)
Produk merek NovaBay Pharmaceuticals Inc.

A portfolio analyst assesses the creditworthiness of NovaBay Pharmaceuticals (NBY) through the dynamics of incoming cash flows. The specifics of eye care combined with a narrow product range make revenue sensitive to pricing pressure from pharmacy chains. The volatility of the company's sales reflects operational efficiency and the fundamental quality of asset management in the open market. Steady growth of this indicator minimizes delisting risk, determining the balance between capital protection and yield potential.